Quetiapine Fumarate Tablet
Product Images NDC 87441-074

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 87441-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine 25 mg (8744107401 Quetiapine 25 mg)

Quetiapine Tablets USP 25 mg dosage form in tablet form. The label indicates the active ingredient as quetiapine fumarate USP equivalent to 25 mg quetiapine. It includes storage instructions at 25°C (77°F) with allowable excursions between 15°C and 30°C (59°F to 86°F). The product is repackaged by Unit Dose Solutions, Inc., Raleigh, NC, and distributed by Tuckhoe Enterprises, LLC, Henrico, VA. The label also contains a barcode and space for lot number, expiration date, and quantity.*

FDA Label Image

Molecular Structure (E5317b83 F487 441b 9095 A25a9560bc54 01)

Chemical structure of quetiapine fumarate showing the quetiapine molecule with its aromatic and heterocyclic rings, linked to the fumarate ion with carboxylate groups.*

FDA Label Image

Figure 1 (E5317b83 F487 441b 9095 A25a9560bc54 02)

A line chart depicting the proportion of patients with relapse over time in weeks. The y-axis shows relapse percentage up to 100%, and the x-axis shows time up to 100 weeks. Two lines compare groups labeled QTP+LI/VAL (dashed) and PLA+LI/VAL (solid), illustrating different relapse rates across the study period.*

FDA Label Image

Figure 2 (E5317b83 F487 441b 9095 A25a9560bc54 03)

A Kaplan-Meier plot depicting the proportion of patients with relapse (%) over time (weeks). Two groups are compared: one labeled QTP+LI/VAL represented by a dashed line and the other PLA+LI/VAL represented by a solid line, showing differences in relapse rates over a 100-week period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.